| 26/07/19 | | 08:00:02 | 26 Jul 2019 | | | FDA approves Feraccru® with a broad label | Shield Therapeutics PLC | RNS |
| 02/07/19 | | 13:00:54 | 2 Jul 2019 | | | Additional Listing | Shield Therapeutics PLC | RNS |
| 13/06/19 | | 15:16:32 | 13 Jun 2019 | | | Result of AGM | Shield Therapeutics PLC | RNS |
| 03/06/19 | | 08:00:09 | 3 Jun 2019 | | | Update on Legal Proceedings | Shield Therapeutics PLC | RNS |
| 08/05/19 | | 08:00:05 | 8 May 2019 | | | Appointment of Joint Broker | Shield Therapeutics PLC | RNS |
| 02/05/19 | | 08:00:05 | 2 May 2019 | | | Investor presentation | Shield Therapeutics PLC | RNS |
| 01/05/19 | | 12:58:45 | 1 May 2019 | | | Additional Listing | Shield Therapeutics PLC | RNS |
| 30/04/19 | | 08:00:04 | 30 Apr 2019 | | | 2018 Annual Report and 2019 AGM Notice | Shield Therapeutics PLC | RNS |
| 26/04/19 | | 19:05:26 | 26 Apr 2019 | | | PDMR Acquisition of Shares | Shield Therapeutics PLC | RNS |
| 24/04/19 | | 08:00:04 | 24 Apr 2019 | | | Major extension to approval in Switzerland | Shield Therapeutics PLC | RNS |
| 17/04/19 | | 18:06:43 | 17 Apr 2019 | | | Grant of share options | Shield Therapeutics PLC | RNS |
| 17/04/19 | | 18:01:46 | 17 Apr 2019 | | | PDMR Acquisition of Shares and Additional Listing | Shield Therapeutics PLC | RNS |
| 17/04/19 | | 17:56:42 | 17 Apr 2019 | | | PDMR Acquisition of Shares | Shield Therapeutics PLC | RNS |
| 11/04/19 | | 17:40:13 | 11 Apr 2019 | | | Holding(s) in Company | Shield Therapeutics PLC | RNS |
| 08/04/19 | | 16:42:50 | 8 Apr 2019 | | | Additional Listing | Shield Therapeutics PLC | RNS |
| 03/04/19 | | 08:00:04 | 3 Apr 2019 | | | Final Results | Shield Therapeutics PLC | RNS |
| 01/04/19 | | 18:44:59 | 1 Apr 2019 | | | Additional Listing | Shield Therapeutics PLC | RNS |
| 01/04/19 | | 13:00:01 | 1 Apr 2019 | | | Change of Adviser | Shield Therapeutics PLC | RNS |
| 14/03/19 | | 15:31:22 | 14 Mar 2019 | | | Positive decision on Feraccru®'s process patent | Shield Therapeutics PLC | RNS |
| 04/03/19 | | 07:00:07 | 4 Mar 2019 | | | Positive results for Feraccru® in AEGIS-H2H study | Shield Therapeutics PLC | RNS |
| 29/01/19 | | 07:00:07 | 29 Jan 2019 | | | Positive results of AEGIS-CKD study | Shield Therapeutics PLC | RNS |
| 24/01/19 | | 07:00:05 | 24 Jan 2019 | | | Business and trading update | Shield Therapeutics PLC | RNS |
| 23/01/19 | | 10:19:39 | 23 Jan 2019 | | | Investor presentations | Shield Therapeutics PLC | RNS |
| 22/01/19 | | 07:00:09 | 22 Jan 2019 | | | Appointment of Chairman | Shield Therapeutics PLC | RNS |
| 13/12/18 | | 07:00:02 | 13 Dec 2018 | | | US New Drug Application PDUFA date for Feraccru | Shield Therapeutics PLC | RNS |
| 05/12/18 | | 10:04:41 | 5 Dec 2018 | | | UK launch of Feraccru® by Norgine | Shield Therapeutics PLC | RNS |
| 03/12/18 | | 07:00:08 | 3 Dec 2018 | | | New Drug Application for Feraccru® | Shield Therapeutics PLC | RNS |
| 09/11/18 | | 15:46:23 | 9 Nov 2018 | | | Holding(s) in Company | Shield Therapeutics PLC | RNS |
| 08/11/18 | | 18:21:09 | 8 Nov 2018 | | | Holding(s) in Company | Shield Therapeutics PLC | RNS |
| 01/10/18 | | 14:54:09 | 1 Oct 2018 | | | Notification Of Major Holdings | Shield Therapeutics PLC | RNS |
| 01/10/18 | | 08:00:05 | 1 Oct 2018 | | | Submission of an NDA for Feraccru® with the FDA | Shield Therapeutics PLC | RNS |
| 24/09/18 | | 14:06:35 | 24 Sept 2018 | | | Director/PDMR Shareholding | Shield Therapeutics PLC | RNS |
| 24/09/18 | | 14:02:25 | 24 Sept 2018 | | | Holding(s) in Company | Shield Therapeutics PLC | RNS |
| 13/09/18 | | 08:00:07 | 13 Sept 2018 | | | AEGIS-H2H Completion of Recruitment | Shield Therapeutics PLC | RNS |
| 26/07/18 | | 08:00:23 | 26 Jul 2018 | | | Appointment of Non-Executive Director | Shield Therapeutics PLC | RNS |
| 09/07/18 | | 17:27:33 | 9 Jul 2018 | | | Holdings in Company | Shield Therapeutics PLC | RNS |
| 09/07/18 | | 17:26:20 | 9 Jul 2018 | | | Holdings in Company | Shield Therapeutics PLC | RNS |
| 28/06/18 | | 08:00:12 | 28 Jun 2018 | | | Data from real-world clinical use of Feraccru | Shield Therapeutics PLC | RNS |
| 14/06/18 | | 08:00:03 | 14 Jun 2018 | | | Positive top-line results from AEGIS-PAED PK study | Shield Therapeutics PLC | RNS |
| 05/06/18 | | 08:00:08 | 5 Jun 2018 | | | Directorate Change | Shield Therapeutics PLC | RNS |
| 05/06/18 | | 08:00:06 | 5 Jun 2018 | | | 2017 Annual Report and 2018 AGM Notice | Shield Therapeutics PLC | RNS |
| 15/05/18 | | 19:21:55 | 15 May 2018 | | | Grant of share options | Shield Therapeutics PLC | RNS |
| 04/05/18 | | 10:20:35 | 4 May 2018 | | | Holding(s) in Company | Shield Therapeutics PLC | RNS |
| 03/05/18 | | 18:26:28 | 3 May 2018 | | | Holding(s) in Company | Shield Therapeutics PLC | RNS |
| 02/05/18 | | 12:00:25 | 2 May 2018 | | | Price Monitoring Extension | Shield Therapeutics PLC | RNS |
| 11/04/18 | | 08:00:04 | 11 Apr 2018 | | | Preliminary Results for the Year Ended 31 Dec 17 | Shield Therapeutics PLC | RNS |
| 06/04/18 | | 08:00:45 | 6 Apr 2018 | | | Appointment of Non-Executive Director | Shield Therapeutics PLC | RNS |
| 06/04/18 | | 08:00:04 | 6 Apr 2018 | | | Results of Pre-Submission Meeting with FDA | Shield Therapeutics PLC | RNS |
| 27/03/18 | | 08:00:06 | 27 Mar 2018 | | | Broadening of Feraccru indication | Shield Therapeutics PLC | RNS |
| 16/03/18 | | 07:00:04 | 16 Mar 2018 | | | Update on the AEGIS-CKD study | Shield Therapeutics PLC | RNS |
